Fundz

Tarsier Pharma Appoints Emilee Fulcher as Vice President of Clinical Affairs

TAKEN PRIVATEMay 28, 2024

Position

Vice President

Company

Tarsier Pharma

Emilee Fulcher
emilee@tarsierpharma.com
Zichron YaacovBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Tarsier Pharma proudly announces the appointment of Emilee Fulcher as Vice President of Clinical Affairs. In her new role, Emilee Fulcher will spearhead the execution of the TRS01 and TRS02 clinical programs towards the advancement of Tarsier Pharma's pipeline for Dazdotuftide (TRS), a novel multi-target drug for the treatment of ocular blinding diseases.

Who to call at Tarsier Pharma, and when

A new leader at Tarsier Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tarsier Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tarsier Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tarsier Pharma. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tarsier Pharma

Location

Zichron Yaacov, Haifa District, Israel

About

Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The company's most advanced candidate, TRS01 – an eye drop formulation of dazdotuftide, is entering its second phase 3 trial supported by a SPA agreement from the FDA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tarsier Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Emilee
Likely contact at this company
••••••••@••••••••

See Emilee's verified email →

Ashley
Likely contact at this company
••••••••@••••••••

See Ashley's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tarsier Pharma's next move

Learn about Strategic plan

Tarsier Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.